流行病学趋势和与脑髓母细胞瘤患者的存活相关的因素:一项为期45年的基于人口的回顾性研究
Dongjie He1, Yahui Yang2, Peiwen Wu3
1Department of Radiation Oncology, Air Force Medical University Tangdu Hospital, Xi'an, China.
概括
脑髓母细胞瘤 (MB) 发病率稳定,但患病率正在上升. 化疗在高风险的MB患者中改善了生存率,突出了关键的预后因素.
科学领域:
- 神经瘤学神经瘤学
- 流行病学 流行病学
- 癌症研究 癌症研究
背景情况:
- 骨髓母细胞瘤 (MB) 是一种主要的大脑瘤,具有有限的最新流行病学数据和长期结果信息.
- 了解MB发病率,流行率和治疗的当前趋势对于公共卫生规划和患者护理至关重要.
研究的目的:
- 分析最新的流行病学数据和使用基于人口的数据集来分析脑髓母细胞瘤 (MB) 的长期结果.
- 为了确定MB发病率,流行率和治疗方式的趋势.
- 确定影响MB患者总生存 (OS) 和癌症特异性生存 (CSS) 的预后因素.
主要方法:
- 利用来自监测,流行病学和最终结果 (SEER) 数据库的临床和流行病学数据.
- 采用Joinpoint回归模型来分析发病率,流行率和治疗趋势.
- 应用Cox危险和竞争风险模型来评估生存结果 (OS和CSS).
主要成果:
- 到2019年,MB发病率保持稳定,在每10万人口中为0.15;男性发病率呈现上升趋势.
- 观察到20年限期患病率的显著增加,从1999年的0.00016%增加到2018年的0.00203%.
- 多变量分析确定了年龄,诊断年份,组织学,阶段,手术和放射治疗作为显著的预后因素. 化疗使用与高风险群体的更好的生存相关.
结论:
- 脑膜母细胞瘤的发病率稳定,而其患病率显著增加.
- 这项研究确定了脑髓母细胞瘤的关键预后因素.
- 化疗在高风险脑髓母细胞瘤患者群体中表现出良好的预后,这表明它在治疗策略中的重要性.
相关概念视频
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
Kaplan-Meier Approach
129
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
129
Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Introduction To Survival Analysis
215
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
215
Assumptions of Survival Analysis
121
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
121


